Facts about NHE

Column

NHE 2023

Historical NHE, 2023

    • NHE grew 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP).

    • Medicare spending grew 8.1% to $1,029.8 billion in 2023, or 21 percent of total NHE.

    • Medicaid spending grew 7.9% to $871.7 billion in 2023, or 18 percent of total NHE.

    • Private health insurance spending grew 11.5% to $1,464.6 billion in 2023, or 30 percent of total NHE.

    • Out of pocket spending grew 7.2% to $505.7 billion in 2023, or 10 percent of total NHE.

    • Other Third Party Payers and Programs and Public Health Activity spending declined 3.1% in 2023 to $563.4 billion, or 12 percent of total NHE.

    • Hospital expenditures grew 10.4% to $1,519.7 billion in 2023, faster than the 3.2% growth in 2022.

    • Physician and clinical services expenditures grew 7.4% to $978.0 billion in 2023, faster growth than the 4.6% in 2022.

    • Prescription drug spending increased 11.4% to $449.7 billion in 2023, faster than the 7.8% growth in 2022.

    • The largest shares of total health spending were sponsored by the federal government (32 percent) and the households (27 percent). The private business share of health spending accounted for 18 percent of total health care spending, state and local governments accounted for 16 percent, and other private revenues accounted for 7 percent.


Source: https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet

Projected NHE

Projected NHE, 2023-2032

    • Over 2023-32 average NHE growth (5.6%) is projected to outpace that of average GDP growth (4.3%), resulting in an increase in the health spending share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032.

    • NHE spending is expected to have grown 7.5% in 2023, faster than GDP growth of 6.1%.

    • Reflects broad increases in the use of care associated with the insured share of the population of 93.1% - an unprecedented high.

    • Largely related to a record-high level of Medicaid enrollment (91.2M) in 2023, as well as gains in direct-purchase enrollment (8.3M) over 2023-25.

    • Health price growth remains modest, though faster than pre-pandemic.

    • By 2032 the insured share falls to 90.7%.

    • Consistent with the President’s Budget, Medicaid enrollment is projected to decline to 81.0M in 2024 and slightly further to 79.4M by 2025 following the expiration of the continuous enrollment requirement.

    • Direct-purchase enrollment is expected to decline by 7.3M in 2026 (-19.2%) due to expiration of the IRA’s temporary extension of enhanced subsidies and associated temporary Special Enrollment Period (SEP).

    • Over 2027-32, personal health care price inflation and growth in the use of health care services and goods contribute to projected health spending that grows at a faster rate than the rest of the economy.


Source: https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet

IRA impact

Inflation Reduction Act (IRA) Impacts on NHE

    • Initially, upward pressure on Medicare “retail” prescription drug spending is expected as a result of the IRA’s Part D benefit restructuring ($2,000 cap on out-of-pocket spending on Part D; rebates shift from program to point of sale when drug negotiations begin).

    • Conversely, downward pressure on Medicare spending is expected associated with (manufacturer discounts for the low-income population (starting in 2025) and IRA provisions that are associated with drug price negotiations and the linking of price increases to the Consumer Price Index (CPI).

    • Beginning in 2028, spending growth rates for Medicare outpatient hospital and physician and clinical services are expected to be lower than they otherwise would have been, mainly because the IRA’s drug negotiation provision will begin to apply to Medicare Part B drugs.

    • The NHE projections show lower out-of-pocket spending associated with the IRA due to more generous Medicare Part D benefits reflecting the elimination of the 5% coinsurance for catastrophic coverage in 2024, the implementation of a $2,000 cap on out-of-pocket spending on Part D drugs in 2025, and the applicability of drug price negotiations beginning in 2026. |


Source: https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet

Expenditures

Column

Population

NHE

NHE/GDP

NHE per capita

Type

Uninsured and ACA

Column

In 2010 the ACA was enacted. At that time, there were 48.1 million uninsured.
In 2023 the number of uninsured was 24.9 million; the number of people insured in Marketplace 16.2 million.

Insurance

Column

Medicare/Medicaid Spending

Medicare/Medicaid Enrollments

Private insurance

Medicare by states

Notes


NOTES

Data is from https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical. Relevant Excel files are in NHE Tables (Zip).

Affordable Care Act

Medicaid coverage and the 2021 American Rescue Plan Act
(This section is taken from KFF)


health-exp/